One of Texas A&M’s top researchers is leading a clinical trial that quickly could bring a treatment for COVID-19.

To be successful, Dr. Jeffrey Cirillo needs about 700 participants in Texas for the Phase 4 trial. Initially, only medical professionals are eligible to take part because, as Dr. Cirillo says, “We need to find a way to protect health care workers.”

Dr. Cirillo is using an existing vaccine for TB as a possible treatment that boosts a person’s immune system. The clinical trial is designed to show if the vaccine, BCG, mitigates the effects of COVID-19, making it less deadly.

I talked with Dr. Cirillo recently for the latest episode of “COVID-19: The Texas A&M System Responds.” You also can see my interview with Greg Hartmann, COO and SVP of the Texas A&M Health Science Center, on the same show.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.